Phillips 66
PSX
276.08
+4.46
+1.64%
Phillips 66
US · PSX
#204 by market cap
Listed 1970
276.08
+4.46
+1.64%
Live - 5344 symbols - heartbeat 209s ago
· 2026-10-08 09:59
Pre-market
275.03
+1.26%
After-hours
271.62
0.00%
Overnight
273.41
+0.66%
- Market cap
- 110.16B
- P/E (TTM)i
- 15.76
- P/Bi
- 3.50
- EPSi
- 10.79
- Div yieldi
- 1.79%
- 52W posi
- 99%
Reader sentiment
Are you bullish or bearish on PSX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Ownership Signal how this is computed
Distributing
- The number of reporting institutions decreased by 6 in the most recent period (2026/Q3).
- Total institutional ownership (as a % of shares) was little changed.
Institutional ownership
- Held by institutions
- 80.37% -0.02pp
- Institutions
- 2,312 -6
- As of
- 2026/Q3 vs. prior period
Ownership vs. money flow
AlignedInstitutions trimmed shares last reporting period, and the stock has seen net outflows in main-fund flow over the last 20 trading sessions - the two line up.
Institutional ownership changes are reported quarterly with a lag; fund-flow data is daily. Treat this as a directional cross-check, not a precise timing signal.
Holder types
Mutual Fund59.63%
Hedge Fund8.31%
Public Company7.17%
Government Pension Fund1.67%
Private Company1.40%
Sovereign Wealth Fund1.12%
Family Office/Trust0.40%
Insurance Company0.32%
Bank/Investment Bank0.14%
Other19.85%
Top holders as of 2026-06-30
BlackRock
8.55% · 34.11M sh
Vanguard Capital Management, LLC
7.13% · 28.44M sh
State Street Global Advisors
6.53% · 26.04M sh
Vanguard Portfolio Management, LLC
5.57% · 22.21M sh
Elliott Management Corporation
4.82% · 19.25M sh
Other
67.41%
Wells Fargo & Company
3.11% · 12.43M sh
Geode Capital Management, LLC
2.79% · 11.12M sh
BNY Mellon Asset Management
1.44% · 5.75M sh
UBS Asset Management
1.19% · 4.76M sh
AQR Capital Management
1.10% · 4.40M sh
Bar length is relative to the largest holder shown here, not to 100% of the company.
Insiders
50 filings tracked · 24 buys · 25 sells
| Name | Role | Stake |
|---|---|---|
| Timothy Roberts | Executive Vice President of Midstream & Chemicals | 0.02% |
| Kevin Mitchell | Chief Financial Officer | 0.02% |
| Mark Lashier | Chief Executive Officer | 0.01% |
| John Lowe | Independent Director | 0.01% |
| Brian Mandell | Executive Vice President of Marketing & Commercial | 0.01% |
| Glenn Tilton | Lead Independent Director | 0.01% |
| Ann Kluppel | Vice President | 0.01% |
| Richard Harbison | Executive Vice President of Refining | 0.01% |
| Gary Adams | Independent Director | 0.01% |
| Sigmund Cornelius | Director | 0.01% |
Insider transactions most recent Form 4 filings
| Date | Name | Role | Type | Shares | Price |
|---|---|---|---|---|---|
| 2026-09-15 | Brian Mandell | Executive Vice President of Marketing & Commercial | Derivative Exercise and Sale | -23,400 | $74.70–265.06 |
| 2026-09-09 | Ann Kluppel | Vice President | Other Disposition | -40 | -- |
| 2026-08-11 | Richard Harbison | Executive Vice President of Refining | Derivative Exercise and Sale | -52,100 | $74.70–223.76 |
| 2026-08-10 | Brian Mandell | Executive Vice President of Marketing & Commercial | Derivative Exercise and Sale | -33,300 | $74.70–215.00 |
| 2026-08-09 | Lisa Davis | Independent Director | Open Market Disposition | -1,515 | $207.21–208.99 |
| 2026-08-09 | Ann Kluppel | Vice President | Derivative Exercise and Sale | -7,834 | $89.05–215.00 |
| 2026-07-08 | Kevin Mitchell | Chief Financial Officer | Derivative Exercise and Sale | -11,021 | $94.97–190.03 |
| 2026-05-10 | Kevin Mitchell | Chief Financial Officer | Derivative Exercise and Sale | -30,000 | $94.85–171.56 |
| 2026-05-05 | Kevin Meyers | Independent Director | Open Market Acquisition | +175 | $173.13 |
| 2026-03-31 | Donald Baldridge | Executive Vice President of Midstream & Chemicals | Sale to Issuer | -5,885 | $177.21 |
| 2026-03-29 | Kevin Mitchell | Chief Financial Officer | Derivative Exercise and Sale | -15,629 | $94.97–190.07 |
| 2026-03-16 | Kevin Meyers | Independent Director | Open Market Acquisition | +175 | $173.20 |
| 2026-03-15 | Kevin Meyers | Independent Director | Other Acquisition | +949 | $172.84 |
| 2026-03-15 | Howard Ungerleider | Independent Director | Other Acquisition | +949 | $172.84 |
| 2026-03-12 | Lisa Davis | Independent Director | Open Market Disposition | -3,800 | $174.37 |
| 2026-03-11 | Brian Mandell | Executive Vice President of Marketing & Commercial | Derivative Exercise and Sale | -42,800 | $89.57–169.53 |
| 2026-03-05 | Kevin Meyers | Independent Director | Initial Statement of Beneficial | 0 | -- |
| 2026-03-04 | Kevin Mitchell | Chief Financial Officer | Derivative Exercise and Sale | -21,800 | $94.85–168.22 |
| 2026-02-16 | Donald Baldridge | Executive Vice President of Midstream & Chemicals | Open Market Disposition | -7,500 | $160.00 |
| 2026-02-09 | Mark Lashier | Chief Executive Officer | Other Acquisition | +29,148 | $156.70 |
Form 4 filings, most recent per company. "Other Derivative Acquisition" rows are mostly RSU/option vesting, not open-market buying - the Type column says which.
Quote time 2026-10-08 09:59:32 · For reference only, not investment advice and not tailored to your situation.